Invention Grant
- Patent Title: Siglec neutralizing antibodies
-
Application No.: US16082959Application Date: 2017-03-07
-
Publication No.: US11078274B2Publication Date: 2021-08-03
- Inventor: Stephanie Cornen , Benjamin Rossi , Nicolai Wagtmann
- Applicant: INNATE PHARMA
- Applicant Address: FR Marseilles
- Assignee: INNATE PHARMA
- Current Assignee: INNATE PHARMA
- Current Assignee Address: FR Marseilles
- Agency: Saliwanchik, Lloyd & Eisenschenk
- International Application: PCT/EP2017/055364 WO 20170307
- International Announcement: WO2017/153433 WO 20170914
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K47/68 ; A61P35/00 ; C12N5/12 ; G01N33/574
Abstract:
This invention relates to agents that bind human Siglecs having inhibitory activity in immune cells, and that neutralize the inhibitory activity of such Siglec. Such agents can be used for the treatment of cancers or infectious disease.
Public/Granted literature
- US20190085077A1 SIGLEC NEUTRALIZING ANTIBODIES Public/Granted day:2019-03-21
Information query
